PETRICHOR SCION THERAPEUTICS
Venture capitalNew York
Fund manager profile
PETRICHOR SCION THERAPEUTICS is a venture fund manager based in New York. SEC filings show 1 venture fund on record, most recently PETRICHOR SCION THERAPEUTICS LLC filed March 2023.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 1 of 2 portfolio companiesBiotech ×1Medical Devices ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathBy year:2024 · 12017 · 12 dated
Avalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases.
BiotechMedical DevicesBaltimore, US
Mariam Morris(Executive Officer)Ronald Marcus(Executive Officer)Uli Hacksell(Executive Officer, Director)John Kaiser(Executive Officer)James Vornov(Executive Officer)Blake M. Paterson(Executive Officer, Director)
Board seatAaron Kantoff· per SEC Form D · $200M raise · filed Apr 2024
Co-investorsNew Enterprise Associates (NEA)OrbiMed
New York, US
Board seatAaron Kantoff· per SEC Form D · $50M raise · filed Jun 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- Where is PETRICHOR SCION THERAPEUTICS located?
- PETRICHOR SCION THERAPEUTICS is headquartered in New York, US.